Beryl Drugs Ltd vs Vivo Bio Tech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Beryl Drugs Ltd is ₹ 21 as of 06 May 15:30 . The P/E Ratio of Beryl Drugs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Vivo Bio Tech Ltd changed from 11.3 on March 2021 to 8 on March 2025 . This represents a CAGR of -6.67% over 5 years The Market Cap of Beryl Drugs Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Vivo Bio Tech Ltd changed from ₹ 64.28 crore on March 2021 to ₹ 57.3 crore on March 2025 . This represents a CAGR of -2.27% over 5 years The revenue of Beryl Drugs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Vivo Bio Tech Ltd for the Dec '25 is ₹ 13.65 crore as compare to the Sep '25 revenue of ₹ 13.24 crore. This represent the growth of 3.1% The ebitda of Beryl Drugs Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Vivo Bio Tech Ltd for the Dec '25 is ₹ 5.63 crore as compare to the Sep '25 ebitda of ₹ 5.55 crore. This represent the growth of 1.44% The net profit of Beryl Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Vivo Bio Tech Ltd changed from ₹ 0.17 crore to ₹ 1.25 crore over 7 quarters. This represents a CAGR of 212.69% The Dividend Payout of Beryl Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Vivo Bio Tech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Beryl Drugs Ltd

Beryl Drugs Limited was incorporated on August 24, 1993.
The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993.
The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally.
It offers I.V. fluids, and a range of small and large volume injectables.
It provides a range of eye/ear drops, veterinary products, and injections.

About Vivo Bio Tech Ltd

Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines.
The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies, Genotoxicity screening, Analytical services etc.
Their experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. The Company stands as a premier and primary provider of SPF lab animals in India.
It holds the distinction of being the largest breeder and distributor of rodent models, in addition to offering custom rodent models and stem cell products through Cyagen Biosciences.

FAQs for the comparison of Beryl Drugs Ltd and Vivo Bio Tech Ltd

Which company has a larger market capitalization, Beryl Drugs Ltd or Vivo Bio Tech Ltd?

Market cap of Beryl Drugs Ltd is 10 Cr while Market cap of Vivo Bio Tech Ltd is 61 Cr

What are the key factors driving the stock performance of Beryl Drugs Ltd and Vivo Bio Tech Ltd?

The stock performance of Beryl Drugs Ltd and Vivo Bio Tech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Beryl Drugs Ltd and Vivo Bio Tech Ltd?

As of May 6, 2026, the Beryl Drugs Ltd stock price is INR ₹21.0. On the other hand, Vivo Bio Tech Ltd stock price is INR ₹27.71.

How do dividend payouts of Beryl Drugs Ltd and Vivo Bio Tech Ltd compare?

To compare the dividend payouts of Beryl Drugs Ltd and Vivo Bio Tech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.